Both Sides of the Table

APRIL 21, 2020

Several years ago I made an appearance in a burgeoning new podcast called “20 Minute VC,” which by now needs no introduction. Harry was gracious enough to invite me back so this past week we recorded an episode discussing the current market environment. Please download the episode here , if for no other reason than to make Harry happy :) but I’ve also included some quick notes below including a few notes I didn’t share in the podcast (and vice versa by the way?

VC 263

VC hospitality founder support 263

Dream It

APRIL 21, 2020

When pitching investors, remember that your ask is like porridge; it follows the goldilocks ratio and has to be just right. Asking for too much or too little funding will raise red flags with investors and cause you to lose credibility. So the question remains: what is the appropriate amount of funding founders should request? This is a difficult question to answer.

ventures 351

ventures pitching frameworks founder 351

A VC: Musings of a VC in NYC

APRIL 21, 2020

I woke up to this tweet this morning: @fredwilson someone has hijacked your cap table link in this post – it now goes out to some random company rather than your template [link] — John Henderson (@johnhenderson) April 21, 2020. I went to that blog post and clicked on the link and sure enough someone had swapped out my cap table template from 2011 with their own cap table.

education 187

education VC technology entrepreneurship 187

Impact Hub

APRIL 21, 2020

Now, more than ever before, the world is connected by something smaller than the human eye can see. Yet its impact is beyond measure. A pathogen. Never has the world experienced a pandemic that has reached every corner of the globe: from Asia to Africa and from Europe to the Pacific and beyond, every country is battling against COVID-19. . The Impact Hub network brings together like-minded social entrepreneurs, innovators, partners, and industry professionals who are passionate about creating la

collaboration 36

collaboration innovation mix-use board 36

Advertisement

Lack of digitalization decreases business competitiveness. To thrive, embracing modern solutions becomes essential. The approach to digitalization often aligns with a company's business model. This shift not only boosts productivity but also automates processes and improves security. The tech market offers a wealth of technologies tailored for management, planning, and forecasting, replacing outdated pen-and-paper methods.

technology

OurCrowd

APRIL 21, 2020

NEW YORK, April 22, 2020 (GLOBE NEWSWIRE) — Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and Signals Analytics, the next generation advanced analytics platform that leverages external data to uncover trends and novel insights, today announced a joint offering that helps life sciences companies to identify new opportunities, mitigate investment risks and accelerate the drug development process.

accelerator 36

accelerator opportunity development investing 36

OurCrowd

APRIL 21, 2020

OurCrowd, the world’s largest crowdfunding venture investment platform, has announced it would lead a $12 million funding round in MigVax Corporation – a startup that is developing a COVID-19 vaccine. Read more here. The post [MigVax and OurCrowd in Crowdfund Insider] OurCrowd Backs COVID-19 Vaccination Company MigVax appeared first on OurCrowd.

development 41

development ventures investing investment 41

Tomasz Tunguz

APRIL 21, 2020

If I start a salacious tweetstorm that our local bank is running out of money, that rumor will circulate quickly. Eventually, the rumor will trigger a bank run. By tomorrow, the bank will face insolvency, even though it was business as usual at the bank this morning. This is the idea behind Narrative Economics. Robert Shiller wrote Narrative Economics , in which he explores how stories impact the economy.

development 100

development support founder 100

OurCrowd

APRIL 21, 2020

That is why today OurCrowd announced our decision to back Israel’s leading coronavirus vaccine candidate being developed by MigVax, based on research from the Migal Galilee Research Institute in Kiryat Shemonah in the Galilee. Read more here. The post [MigVax and OurCrowd in Medium] Six Reasons Why OurCrowd is Investing in This Israeli COVID-19 Vaccine appeared first on OurCrowd.

investing 41

investing investment development 41

OurCrowd

APRIL 21, 2020

Jerusalem-based OurCrowd announced today that it would lead a $12 million investment in the newly formed startup MigVax, an affiliate of The Migal Galilee Research Institute. Read more here. The post [MigVax and OurCrowd in Forbes] New Developments In Producing A COVID-19 Vaccine And Identifying High-Risk Individuals appeared first on OurCrowd.

development 36

development investing investment startup 36

Advertisement

Outdated or absent analytics won’t cut it in today’s data-driven applications – not for your end users, your development team, or your business. That’s what drove the five companies in this e-book to change their approach to analytics. Download this e-book to learn about the unique problems each company faced and how they achieved huge returns beyond expectation by embedding analytics into applications.

development

OurCrowd

APRIL 21, 2020

Israeli startup’s behavioral biometrics technology protects some of the world’s largest financial institutions and is moving into other verticals. Read more here. The post [BioCatch in Israel21C] BioCatch fintech company reports $145 million investment appeared first on OurCrowd.

investing 36

investing investment technology 36

OurCrowd

APRIL 21, 2020

MigVax, an Israeli startup that’s affiliated with the Migal Galilee Research Institute, thinks it can speed up this process by quite a bit, in part, because it had already worked on building a framework for the Infectious Bronchitis Virus, a coronavirus that infects chickens, and that has proven to be safe in animals. Read more here. The post [MigVax and OurCrowd in TechCrunch] MigVax raises $12M for its COVID-19 vaccine efforts appeared first on OurCrowd.

frameworks 41

frameworks startup 41

OurCrowd

APRIL 21, 2020

HONG KONG & JAKARTA, Indonesia–(BUSINESS WIRE)–EMQ, a global financial settlement network, today announced a significant enhancement to its cross-border payment solution, which enables businesses both locally and globally to seamlessly expand their reach and further improve their payment capabilities with greater speed, certainty and increased flexibility.

enablement 36

enablement networking 36

OurCrowd

APRIL 21, 2020

VENTURA, Calif.–(BUSINESS WIRE)–Nexa3D, the maker of ultrafast stereolithography production 3D printers, announced today the launch of a service to deliver NexaShield PPE, a groundbreaking initiative in the midst of the COVID-19 pandemic that harnesses the power of 3D printing to produce protective gear for healthcare and other essential workers on the frontline as the nation is gearing for an eventual phased reopening of markets and workplaces.

36

36

Advertisement

CAPTARGET presents a masterclass in M&A deal sourcing. Learn to cast a wide net, embracing seller self-identification. Consistency is the linchpin: keep the origination process steady for a reliable flow of opportunities. Diversify your tactics, employing various tools and vendors. Tech matters! Understand DNS settings, domain authority, and brand presence for optimal outreach.

opportunity

OurCrowd

APRIL 21, 2020

Today we announced our decision to back Israel’s leading coronavirus vaccine candidate. There is nothing more important for the world right now than developing a vaccine against the coronavirus. Many things are necessary for us to get through this crisis – testing, medical equipment, personal protection, better therapeutics – but creating a COVID-19 vaccine and deploying it across the globe is the key to preventing millions more from dying and overloading countries’ health systems.

investing 69

investing investment innovation development 69

OurCrowd

APRIL 21, 2020

April 22, 2020 – Kiryat Shemona, Israel – OurCrowd, the world’s largest crowdfunding venture investment platform, based in Jerusalem, today announced that it would lead a $12 million investment in the newly formed MigVax Corp., which will develop a novel COVID-19 vaccine. MigVax, an affiliate of The Migal Galilee Research Institute, is pioneering the effort to develop Israel’s human vaccine against COVID-19.

investing 41

investing investment development ventures 41

OurCrowd

APRIL 21, 2020

Newly formed Israeli Covid-19 vaccine developer MigVax Corp. has raised $12 million led by OurCrowd. MigVax is an affiliate of The Migal Galilee Research Institute in Kiryat Shmona, which is pioneering the effort to develop Israel’s human vaccine against the virus. Read more here. The post [MigVax and OurCrowd in Globes] Israel’s OurCrowd leads $12 million investment to develop COVID-19 vaccine appeared first on OurCrowd.

development 41

development investing investment 41

OurCrowd

APRIL 21, 2020

TEL AVIV — Israeli venture investing platform OurCrowd said on Wednesday it would lead a $12 million investment in the newly formed MigVax Corp, which plans to develop a novel COVID-19 vaccine. Read more here. The post [MigVax and OurCrowd in NY Times] Israel’s OurCrowd Leads $12 Million Investment to Develop COVID-19 Vaccine appeared first on OurCrowd.

development 41

development investing investment ventures 41

Advertisement

Think your customers will pay more for data visualizations in your application? Five years ago, they may have. But today, dashboards and visualizations have become table stakes. Turning analytics into a source of revenue means integrating advanced features in unique, hard-to-steal ways. Download this white paper to discover which features will differentiate your application and maximize the ROI of your analytics.

OurCrowd

APRIL 21, 2020

TEL AVIV (Reuters) – Israeli venture investing platform OurCrowd said on Wednesday it would lead a $12 million investment in the newly formed MigVax Corp, which plans to develop a novel COVID-19 vaccine. Read more here. The post [MigVax and OurCrowd in Reuters] Israel’s OurCrowd leads $12 million investment to develop COVID-19 vaccine appeared first on OurCrowd.

development 41

development investing investment ventures 41